INNAVIRVAX has a total of 24 patent applications. Its first patent ever was published in 2012. It filed its patents most often in WIPO (World Intellectual Property Organization), Brazil and Canada. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are MULTIVIR INC, ADVAXIS INC and NOVOPHARM BIOTECH INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | Brazil | 2 | |
#3 | Canada | 2 | |
#4 | China | 2 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | Serbia | 2 | |
#7 | Australia | 1 | |
#8 | EAPO (Eurasian Patent Organization) | 1 | |
#9 | Hungary | 1 | |
#10 | India | 1 | |
#11 | Republic of Korea | 1 | |
#12 | Mexico | 1 | |
#13 | Ukraine | 1 | |
#14 | United States | 1 | |
#15 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Therapeutic chemical compounds | |
#5 | Analysing materials | |
#6 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Desfontaines Dominique | 11 |
#2 | Crouzet Joel | 10 |
#3 | Crouzet Joël | 10 |
#4 | Ho Tsong Fang Raphaël | 7 |
#5 | Vieillard Vincent | 7 |
#6 | Ho Tsong Fang Raphael | 7 |
#7 | Debre Patrice | 7 |
#8 | Meyer Laurence | 6 |
#9 | Dominique Desfontaines | 3 |
#10 | Raphaël Ho Tsong Fang | 3 |
Publication | Filing date | Title |
---|---|---|
WO2016184963A1 | Treatment of hiv-infected individuals | |
WO2016184973A1 | Treatment of hiv-infected individuals | |
WO2016184962A1 | Treatment of hiv-infected individuals | |
EP2668959A1 | Immunogenic compounds comprising HIV gp41 peptide coupled to CRM197 carrier protein | |
HUE030649T2 | A method for the prognosis of progression of the hiv disease |